"Dan is an exceptional patent lawyer and strategist who delivers great results for us time and again. He is an invaluable asset to our team."
- Client Testimonial
Dan Shores focuses his practice on counseling clients in biotech, medical device, energy, materials, software, and other technology-based industries, and providing wide-ranging strategic guidance in IP law, particularly during key growth stages when calculated direction is critical to long-term success. In this role, his work consists of a set of interlocking responsibilities, which, taken together, ensure that his clients have the strong IP protection they need.
For his clients, Dan drafts and files patent applications, building claims around core technologies and market differentiators. He generates comprehensive patent and competitive landscape analyses to allow clients to successfully operate and innovate in their respective spaces. He sets up critical IP policies to protect assets, reduce liability, and maximize value. Using in-house IP, he consults on transactions, including in- and out-licensing deals. He analyzes a client’s patent rights from an offensive and defensive perspective, and works with clients on the implications of his analysis. He counsels early-stage clients on the use of IP for investment and structuring exits. He also litigates complex patent infringement disputes in the U.S. federal courts.
Although Dan advises companies at every stage of their development, he has a particularly impressive track record in working with emerging and growth companies, for whom IP is typically both their most valuable asset and a cornerstone of their strategy. For these clients, commercializing and protecting their innovations is of paramount importance. It’s often, literally, a bet-the-company issue. Dan combines his technical education and experience with his legal knowledge and strategic judgment to assist them in accomplishing this task.
Dan has served companies utilizing the following technologies (without limitation): mRNA-based therapies; lipid nanoparticle formulations; genetically modified swine and organs for xenotransplantation; fiber-optic probes for tissue investigation; artificial intelligence for drug discovery; pharmaceutical treatment of rhinitis with levocetirizine; pharmaceutical treatment of hepatitis B with telbivudine; genetically-modified cotton seed; three dimensional printing of buildings and other structures; cybersecurity threat assessment platforms; green hydrogen generation; interactive media systems for healthcare institutions; artificial intelligence (various applications); identification systems for cable-based medical devices; identification of digital positions of interest on media items; implantable glucose-sensing devices; heat-treated glass with multilayer low-emissivity coatings; high throughput genetic seed-chipping technology; automotive and agricultural equipment; pressure-sensitive adhesives; tunable wireless capacitors for cellular phones; mass teleconference software; and integrated electronic securities marketplace systems.
More broadly, Dan works with clients to design, build, and defend robust patent portfolios, protect trade secrets, forge constructive relationships with strategic partners, and prepare for success in both funding rounds and exits. These are often not discrete tasks – the strength of a strategic partnership can be profoundly affected by the nature of a company’s patent portfolio, and the defensibility and positioning of its assets. Accordingly, Dan is frequently called upon to both think several steps ahead, and evaluate a situation from several strategic angles simultaneously.
An engineer by education, and an attorney, with extensive experience in transactional, litigation, procurement, and strategic counseling matters for technology-based companies, Dan is a problem-solver who excels at deciphering key translational aspects of a broad array of technologies. He works to maximize the value and leverage of his client’s technologies, depending on how they seek to commercialize it, and the strategies they intend to employ. Whether a client seeks to enter an already-occupied market as a new participant, or create a blue-ocean market as a first mover, by working with Dan, they can minimize their risk, maximize their opportunity, and both understand and pursue the most strategically appropriate course.
- Speaking Engagement, Boston, MA,
- Speaking Engagement, Paris, France,
- Speaking Engagement, Boston, MA, April 12-14, 2022
- Dan Shores at Innovator Bootcamp During MassBio's State of Partnering, the Premier Life Sciences Innovation SummitSpeaking Engagement,
- Speaking Engagement,
- Speaking Engagement,
- Speaking Engagement, Cambridge, MA,
Author, The mRNA Patent and Competitive Landscape: Pioneers, Litigation Outlook and Big Pharma's Next Moves (Part III), IPWatchdog.com, April 30, 2021
Co-Author, The mNRA IP and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II), IPWatchdog.com, April 21, 2021
Co-Author, The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic (Part I), IPWatchdog.com, April, 11, 2021
Co-Author, IP Assignment Considerations for Emerging Companies, rfemerge.com, March 26, 2021
Co-Author, Emerging Companies: Framework for Leveraging Your IP & Tech, rfemerge.com, December 4, 2020
Author, Breaking Down Moderna's COVID-19 Patent Pledge: Why Did They Do It?, IPWatchdog.com, November 11, 2020
Co-Author, Key Considerations Regarding Early Disclosures and Patent Protection, rfemerge.com, October 18, 2020
Author, Critical Steps for Building Winning Patent Portfolios, rfemerge.com, October 6, 2020
Community & Professional
American Intellectual Property Law Association (AIPLA)
Boston Patent Law Association (BPLA)
Chairman of the Board of Trustees for Massachusetts Maritime Academy
- Brand Protection
- Counseling, Transactions, and Guidance
- Due Diligence
- Emerging Companies
- Hatch-Waxman Litigation
- Inter Partes Review (IPR) and Post Grant Review (PGR)
- International Filings
- International Trade Commission (ITC) Litigation
- Licensing and Transactions
- Opinions, Freedom to Operate, and Patentability Analysis
- Patent Litigation
- Patent Prosecution
- Patent Strategy and Counseling
- Portfolio Management
- Trade Secret Litigation
- Trademark Prosecution
J.D., Georgetown University Law Center
B.S., Engineering, University of New Hampshire
Bar & Court Admissions
- District of Columbia
- U.S. Patent and Trademark Office
- U.S. Supreme Court
- U.S. Court of Appeals for the Federal Circuit
- U.S. District Court for the Commonwealth of Massachusetts